leisure time -WSS

leisure time

author：fashion 2025-09-28 21:06:02 - browse：99

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How Medicaid coverage policies for immigrants impact new moms

leisure time

explore

WSS

Readout Newsletter: New research from Sanofi, Regeneron, etc.

The pink breast cancer awareness ribbon needs a redesign

In early work, researchers turn to CRISPR to treat Alzheimer's

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Why Sanofi got shellacked over its spinoff

hotspot

leisure time

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Maker of FluMist seeks to allow at

Medical records are filled with copy

FDA approves RSV monoclonal antibody for infants, toddlers

Trump demands the U.S. pay no more for drugs than other countries … again

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Emergency medicine has repudiated 'excited delirium.' Now what?

Activists slam private health insurers over coverage restrictions

Sanofi seeks simpler, safer CRISPR sickle cell cure

focus

A public scorecard can help hold safety

The FDA weighs the risks of candy

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Readout Newsletter: What happened with Sarepta's Duchenne data

Medicare has a new plan to address drug shortages

CDC recommends rationing of RSV shot due to shortages

leisure time

explore

explore

knowledge